Par Pharmaceutical to Present at the 27th Annual J.P. Morgan Healthcare Conference

WOODCLIFF LAKE, N.J., Jan. 7 Par Pharmaceutical Companies, Inc. (NYSE: PRX) will be presenting at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at 3:00 pm PST at the Westin St. Francis Hotel.

The audio-only live webcast will be accessible through the J.P. Morgan website at http://metameetings.com/webcasts/jpmorgan/healthcare09 or through the Par website at www.parpharm.com. A replay will be available for approximately 14 days.

About Par

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit www.parpharm.com.

SOURCE Par Pharmaceutical Companies, Inc.

Latest Press Release on General News

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterin...

Nicklaus Children's Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic c...

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FOR...

Philips Delivers First-quarter Results in Line With 2024 Performance Improvement Plan; Resolves the Respironics Personal Injury and Medical Monitoring Litigation in the Us for USD 1.1 Billion

April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 b...

eNeura Achieves Record-Breaking Sales and Announces Notice of Allowance for a New Patent on Prophylactic Treatment of Migraine Headache

Record sales in April accelerating the pathway to profitability New IP will lead the way in changing the way migraine headaches are addressed WEST PALM BEACH, Fla. , April 26, ...